Advancements in Multiomics: Automation of Opal Staining on NanoVIP Saves 80% Reagent Cost and 90% Hands-on Time
May 30, 2023 10:00 ET
|
Omicsveu
Fremont, California, May 30, 2023 (GLOBE NEWSWIRE) -- Omicsveu has achieved a milestone with its NanoVIP instrument – a slide-based automated staining system - fully automating the Opal manual...
Advancements in Multiomics: Automation of Opal Staining on NanoVIP Saves 80% Reagent Cost and 90% Hands-on Time
May 22, 2023 11:58 ET
|
BioGenex
Fremont, California, May 22, 2023 (GLOBE NEWSWIRE) -- Omicsveu has achieved a milestone with its NanoVIP instrument – a slide-based automated staining system - fully automating the Opal manual...
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
April 12, 2023 08:00 ET
|
Akoya Biosciences, Inc.
Enable Cloud Platform trained on high plex spatial imaging datasets across 20,000 samples run on the PhenoCycler® SystemCommercial launch at AACR 2023 Annual Meeting (Akoya booth #1713) ...
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
February 01, 2023 08:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that the company will present results from a...
OmicsVeu Launches An Extensive Line Of Spatial Biology Products For Multiplex Multi-omics
December 13, 2022 07:05 ET
|
BioGenex
Fremont, Dec. 13, 2022 (GLOBE NEWSWIRE) -- OmicsVeu, a wholly owned subsidiary of BioGenex, is pleased to announce the launch of a broad line of Multiplex Multi-Omics products for spatial biology...
Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer
April 19, 2022 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the appointment of Dr. Ehab A. El-Gabry as the company’s...
Akoya Biosciences Appoints Marilee Moy as Chief People Officer
January 20, 2022 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Marilee Moy as Chief People...
Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System
January 13, 2022 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the commercial availability of the PhenoCycler™-Fusion...
Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
January 05, 2022 07:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global life sciences...
Akoya Biosciences Unveils Comprehensive Roadmap of Innovations at Inaugural Spatial Day Event
December 15, 2021 12:00 ET
|
Akoya Biosciences, Inc.
-Company previews an integrated suite of solutions, including the new PhenoCycler™-Fusion System for unbiased spatial discovery, at unprecedented speeds -Innovations include a novel spatial...